Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bioventures 2014 Gp Llc Mpm currently holds 5,125,770 shares of Harpoon Therapeutics, Inc. (HARP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bioventures 2014 Gp Llc Mpm has been a net buyer of HARP stock. They have purchased $6.5M and sold $200.9K worth of shares.
Bioventures 2014 Gp Llc Mpm's most recent insider trade was on Nov 25, 2025, when they sold 42,533 shares at $0.92 per share.
Bioventures 2014 Gp Llc Mpm serves as Executive at Harpoon Therapeutics, Inc. (HARP). They have executed 27 insider transactions totaling $6.7M over their tenure at the company.
Bioventures 2014 Gp Llc Mpm holds the position of Executive at Harpoon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Bioventures 2014 Gp Llc Mpm has shown a buying trading pattern, with $6.5M in total purchases and $200.9K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Bioventures 2014 Gp Llc Mpm was on Feb 12, 2019, when they purchased $3.5M worth of HARP shares. This transaction involved 250,000 shares at $14.00 per share.
Bioventures 2014 Gp Llc Mpm currently owns 5,125,770 shares of Harpoon Therapeutics, Inc. (HARP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bioventures 2014 Gp Llc Mpm's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bioventures 2014 Gp Llc Mpm has 27 Form 4 filings on record as an insider at Harpoon Therapeutics, Inc..
Set alerts for Bioventures 2014 Gp Llc Mpm and 40,000+ other insiders.